^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
GALEAS® Bladder

Company:
Nonacus
Type:
Laboratory Developed Test
Related tests:
Evidence

News

1year
Nonacus launches GALEAS® Bladder, a novel test for the non-invasive detection of bladder cancer (EIN News)
"Nonacus...will launch GALEAS® Bladder, a novel test for the non-invasive detection of bladder cancer at the European Association of Urology (EAU) Annual Meeting, taking place in Milan, March 10-13th 2023...Developed in collaboration with Professor Rik Bryan and Dr Doug Ward at the University of Birmingham UK, GALEAS® Bladder has been validated in over 600 patient samples from 3 UK clinical cohorts. Analyses confirmed the performance of GALEAS® Bladder, showing high diagnostic accuracy (sensitivity >90%, specificity >85%) and good performance across all grades and stages of bladder cancer."
Launch
|
GALEAS® Bladder